Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Syncona Share News (SYNC)
SYNC Share
Price
SYNC Share
News
SYNC Share
Chat
SYNC Share
Trades64
SYNC
Live RNS
SYNC Share
Charts
SYNC Level 2
Console
SYNC Live
Share Price
SYNC Broker
Ratings
SYNC Directors
Deals
SYNC Financial
Diary
SYNC
Fundamentals
SYNC Short
Positions
SYNC
Media
SYNC Company
Research
SYNC Company
Timeline
Syncona Information
Share Price Information for Syncona (SYNC)
Share Price is delayed by 15 minutes
Get Live Data
95.40
-0.80 (-0.83%)
Bid:
96.00
Ask:
96.80
Spread:
0.80 (0.833%)
Market Cap:
£580.22m
Last checked at -
Last checked at 
Intraday Syncona Share Chart
Syncona News
10 Feb 2022
Syncona's Q3 a 'period of significant activity'
(Sharecast News) - Life sciences firm Syncona said on Thursday that the third quarter had been a "period of significant activity", with $674.0m raised...
8 Feb 2022
IN BRIEF: Syncona's Freeline says FLT190 drug "well tolerated"
IN BRIEF: Syncona's Freeline says FLT190 drug "well tolerated"
22 Dec 2021
LONDON MARKET CLOSE: Omicron hope lifts FTSE despite UK virus surge
LONDON MARKET CLOSE: Omicron hope lifts FTSE despite UK virus surge
22 Dec 2021
LONDON MARKET MIDDAY: Stocks edge higher ahead of US growth figures
LONDON MARKET MIDDAY: Stocks edge higher ahead of US growth figures
22 Dec 2021
TOP NEWS SUMMARY: Novartis agrees to buy UK's Gyroscope Therapeutics
TOP NEWS SUMMARY: Novartis agrees to buy UK's Gyroscope Therapeutics
22 Dec 2021
LONDON MARKET OPEN: Stocks mixed; UK economic recovery slows
LONDON MARKET OPEN: Stocks mixed; UK economic recovery slows
22 Dec 2021
Novartis buys UK gene therapy firm Gyroscope for up to USD1.5 billion
Novartis buys UK gene therapy firm Gyroscope for up to USD1.5 billion
22 Dec 2021
Syncona sells Gyroscope to Novartis for up to $1.5bn
(Sharecast News) - Syncona on Wednesday said it had sold its portfolio company Gyroscope Therapeutics Holdings to Novartis for up to $1.5bn (£1.1...
Follow the stocks
